Erratum: An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967–976
ErratumColombo GL, Caruggi M, Di Matteo, et al. 2008. An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967–976.Page 972, Results, r...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-02-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | http://www.dovepress.com/erratumnbspan-economic-evaluation-of-aripiprazole-vs-olanzapine-adapte-a2836 |
id |
doaj-5ebb63c24da047e383dd2b549e53c10b |
---|---|
record_format |
Article |
spelling |
doaj-5ebb63c24da047e383dd2b549e53c10b2020-11-24T20:49:01ZengDove Medical PressNeuropsychiatric Disease and Treatment1176-63281178-20212009-02-012008Issue 612831283Erratum: An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967–976Colombo GLCaruggi MDi Matteoet alErratumColombo GL, Caruggi M, Di Matteo, et al. 2008. An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967–976.Page 972, Results, right column, last paragraph. The second sentence should read:In the simulated cohort of 1000 patients, the values with aripiprazole for 26 weeks showed the avoidance of 34 events of diabetes over 5 years (28 in discounted scenario), resulting in total cost savings of €1,933.24 (€1,472.52 in discounted scenario).Page 973, Table 5:Under Events avoided/1000 schizophrenia patients (5 years): 18 should read 28.Under Cost/metabolic syndrome avoided (5 years): −€2,860.52 should read −€1,852.73. http://www.dovepress.com/erratumnbspan-economic-evaluation-of-aripiprazole-vs-olanzapine-adapte-a2836 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Colombo GL Caruggi M Di Matteo et al |
spellingShingle |
Colombo GL Caruggi M Di Matteo et al Erratum: An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967–976 Neuropsychiatric Disease and Treatment |
author_facet |
Colombo GL Caruggi M Di Matteo et al |
author_sort |
Colombo GL |
title |
Erratum: An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967–976 |
title_short |
Erratum: An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967–976 |
title_full |
Erratum: An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967–976 |
title_fullStr |
Erratum: An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967–976 |
title_full_unstemmed |
Erratum: An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967–976 |
title_sort |
erratum: an economic evaluation of aripiprazole vs olanzapine adapted to the italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. neuropsychiatr dis treat, 4: 967–976 |
publisher |
Dove Medical Press |
series |
Neuropsychiatric Disease and Treatment |
issn |
1176-6328 1178-2021 |
publishDate |
2009-02-01 |
description |
ErratumColombo GL, Caruggi M, Di Matteo, et al. 2008. An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967–976.Page 972, Results, right column, last paragraph. The second sentence should read:In the simulated cohort of 1000 patients, the values with aripiprazole for 26 weeks showed the avoidance of 34 events of diabetes over 5 years (28 in discounted scenario), resulting in total cost savings of €1,933.24 (€1,472.52 in discounted scenario).Page 973, Table 5:Under Events avoided/1000 schizophrenia patients (5 years): 18 should read 28.Under Cost/metabolic syndrome avoided (5 years): −€2,860.52 should read −€1,852.73. |
url |
http://www.dovepress.com/erratumnbspan-economic-evaluation-of-aripiprazole-vs-olanzapine-adapte-a2836 |
work_keys_str_mv |
AT colombogl erratumampnbspaneconomicevaluationofaripiprazolevsolanzapineadaptedtotheitaliansettingusingoutcomesofmetabolicsyndromeandriskfordiabetesinpatientswithschizophrenianeuropsychiatrdistreat4967ampndash976 AT caruggim erratumampnbspaneconomicevaluationofaripiprazolevsolanzapineadaptedtotheitaliansettingusingoutcomesofmetabolicsyndromeandriskfordiabetesinpatientswithschizophrenianeuropsychiatrdistreat4967ampndash976 AT dimatteo erratumampnbspaneconomicevaluationofaripiprazolevsolanzapineadaptedtotheitaliansettingusingoutcomesofmetabolicsyndromeandriskfordiabetesinpatientswithschizophrenianeuropsychiatrdistreat4967ampndash976 AT etal erratumampnbspaneconomicevaluationofaripiprazolevsolanzapineadaptedtotheitaliansettingusingoutcomesofmetabolicsyndromeandriskfordiabetesinpatientswithschizophrenianeuropsychiatrdistreat4967ampndash976 |
_version_ |
1716807078861864960 |